JMP Securities Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $5

JMP Securities analyst Silvan Tuerkcan maintains $Taysha Gene Therapies(TSHA.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of

moomoo News00:32 ET · Ratings

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersGeovax Labs (NASDAQ:GOVX) stock moved upwards by 72.1% to $1.91 during Wednesday's regular session. The company's market cap stands at $4.8 million. Nexalin Technology (NASDAQ:NXL) shares incre

Benzinga12:30 ET

Taysha Gene Therapies Insider Buyers Pleased With US$37m Return On Investment

Insiders who purchased Taysha Gene Therapies, Inc. (NASDAQ:TSHA) shares in the past 12 months are unlikely to be deeply impacted by the stock's 24% decline over the past week. Even after accounting f

Simply Wall StJun 19 08:00 ET

Taysha Gene Therapies Is Maintained at Buy by Chardan Capital

Taysha Gene Therapies Is Maintained at Buy by Chardan Capital

Dow JonesJun 18 17:23 ET

Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financial results and issued FY25 guidance below estimates.Quantum

BenzingaJun 18 13:39 ET

12 Health Care Stocks Moving In Tuesday's Intraday Session

GainersMustang Bio (NASDAQ:MBIO) stock moved upwards by 50.0% to $1.12 during Tuesday's regular session. The company's market cap stands at $31.7 million. Sonoma Pharmaceuticals (NASDAQ:SNOA) shares i

BenzingaJun 18 12:31 ET